SPMED. Co. Ltd.

SPMED is a frontier company in Precision Medicine, located in the Republic of Korea, providing local and international Pharmacogenomics and ADME services. SPMED was founded by researchers and staffs with over 20-year experience and has been involved ever since in the R&D and service for clinical implementation of personalized precision medicine based on genotyping service. Pharmacogenomics (PGx) is quite a new era of genotyping service providing information about the genes that affect the drug response in an individual. The aim of pharmacogenomics service is to improve the drug efficacy to maximum level and reduce the adverse effects to minimum level considering interindividual variations. Pharmacogenomics is recognized as a precise approach to provide useful information for personalized treatment.